Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 3INDUSTRY 1FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Depression 1Breast Neoplasms 1Anxiety Disorders 1

Interventions

Paclitaxel 490Carboplatin 436Gemcitabine 394Docetaxel 385Cisplatin 360pembrolizumab 344Bevacizumab 335Nivolumab 261Pemetrexed 243Capecitabine 221Dexamethasone 213Fluorouracil 211Rituximab 203Trastuzumab 193Cyclophosphamide 190Oxaliplatin 160Erlotinib Hydrochloride 147Ipilimumab 145atezolizumab 144Prednisone 144Cetuximab 142Irinotecan 139Leucovorin 130Doxorubicin 130Sorafenib 120Lenalidomide 119Bortezomib 118Sunitinib 107Everolimus 93130-nm albumin-bound paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × INDUSTRY × Coping Skills × Clear all
NCT01335152 2014-05-07

Online Stress Management and Coping Skills Training for Women With Breast Cancer

Talaria, Inc

Phase 1/2 Completed
100 enrolled
Breast

Anxiety Disorders, Breast Neoplasms, Depression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡